Literature DB >> 34967926

Glycosylation as a regulator of site-specific metastasis.

Wendy E Bindeman1, Barbara Fingleton2.   

Abstract

Metastasis is considered to be responsible for 90% of cancer-related deaths. Although it is clinically evident that metastatic patterns vary by primary tumor type, the molecular mechanisms underlying the site-specific nature of metastasis are an area of active investigation. One mechanism that has emerged as an important player in this process is glycosylation, or the addition of sugar moieties onto protein and lipid substrates. Glycosylation is the most common post-translational modification, occurring on more than 50% of translated proteins. Many of those proteins are either secreted or expressed on the cell membrane, thereby making glycosylation an important mediator of cell-cell interactions, including tumor-microenvironment interactions. It has been recently discovered that alteration of glycosylation patterns influences cancer metastasis, both globally and in a site-specific manner. This review will summarize the current knowledge regarding the role of glycosylation in the tropism of cancer cells for several common metastatic sites, including the bone, lung, brain, and lymph nodes.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bone metastasis; Brain metastasis; Glycosyltransferase; Lung metastasis; Lymph node metastasis; Organotropism; Sialylation

Mesh:

Year:  2021        PMID: 34967926      PMCID: PMC8930623          DOI: 10.1007/s10555-021-10015-1

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  134 in total

Review 1.  Role of protein glycosylation in cancer metastasis.

Authors:  Leticia Oliveira-Ferrer; Karen Legler; Karin Milde-Langosch
Journal:  Semin Cancer Biol       Date:  2017-03-16       Impact factor: 15.707

Review 2.  Targeting Glycosylation: A New Road for Cancer Drug Discovery.

Authors:  Ana Filipa Costa; Diana Campos; Celso A Reis; Catarina Gomes
Journal:  Trends Cancer       Date:  2020-05-04

3.  A novel sialyltransferase inhibitor AL10 suppresses invasion and metastasis of lung cancer cells by inhibiting integrin-mediated signaling.

Authors:  Chi-Hsiang Chiang; Chie-Hong Wang; Hui-Chiu Chang; Shivaji V More; Wen-Shan Li; Wen-Chun Hung
Journal:  J Cell Physiol       Date:  2010-05       Impact factor: 6.384

4.  Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome.

Authors:  Cory D Rillahan; Aristotelis Antonopoulos; Craig T Lefort; Roberto Sonon; Parastoo Azadi; Klaus Ley; Anne Dell; Stuart M Haslam; James C Paulson
Journal:  Nat Chem Biol       Date:  2012-06-10       Impact factor: 15.040

5.  Advances in molecular mechanisms of drugs affecting abnormal glycosylation and metastasis of breast cancer.

Authors:  Huimin Liu; Lele Ma; Junzhi Lin; Bo Cao; Duan Qu; Chuanhong Luo; Wei Huang; Li Han; Hong Xu; Zhenfeng Wu; Runchun Xu; Dingkun Zhang
Journal:  Pharmacol Res       Date:  2020-03-07       Impact factor: 7.658

6.  Bisecting N-acetylglucosamine on K562 cells suppresses natural killer cytotoxicity and promotes spleen colonization.

Authors:  M Yoshimura; Y Ihara; A Ohnishi; N Ijuhin; T Nishiura; Y Kanakura; Y Matsuzawa; N Taniguchi
Journal:  Cancer Res       Date:  1996-01-15       Impact factor: 12.701

7.  Modeling of hypo/hyperglycemia and their impact on breast cancer progression related molecules.

Authors:  Sirin A I Adham; Hasina Al Rawahi; Sumaya Habib; Mansour S Al Moundhri; Alicia Viloria-Petit; Brenda L Coomber
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

Review 8.  Targeted Approaches to Inhibit Sialylation of Multiple Myeloma in the Bone Marrow Microenvironment.

Authors:  Alessandro Natoni; Raghvendra Bohara; Abhay Pandit; Michael O'Dwyer
Journal:  Front Bioeng Biotechnol       Date:  2019-10-04

9.  Systematic analysis of the human tumor cell binding to human vs. murine E- and P-selectin under static vs. dynamic conditions.

Authors:  Sarah Starzonek; Hanna Maar; Vera Labitzky; Daniel Wicklein; Charlotte Rossdam; Falk F R Buettner; Gerrit Wolters-Eisfeld; Cenap Guengoer; Christoph Wagener; Udo Schumacher; Tobias Lange
Journal:  Glycobiology       Date:  2020-08-20       Impact factor: 4.313

View more
  2 in total

1.  Glycobiology of Cancer: Sugar Drives the Show.

Authors:  Jhenifer Santos Dos Reis; Marcos André Rodrigues da Costa Santos; Daniella Pereira Mendonça; Stefani Ingrid Martins do Nascimento; Pedro Marçal Barcelos; Rafaela Gomes Correia de Lima; Kelli Monteiro da Costa; Celio Geraldo Freire-de-Lima; Alexandre Morrot; Jose Osvaldo Previato; Lucia Mendonça Previato; Leonardo Marques da Fonseca; Leonardo Freire-de-Lima
Journal:  Medicines (Basel)       Date:  2022-05-24

2.  Nascent Glycoproteome Reveals That N-Linked Glycosylation Inhibitor-1 Suppresses Expression of Glycosylated Lysosome-Associated Membrane Protein-2.

Authors:  Xinyi Cao; Peiyi Meng; Yuyin Shao; Guoquan Yan; Jun Yao; Xinwen Zhou; Chao Liu; Lei Zhang; Hong Shu; Haojie Lu
Journal:  Front Mol Biosci       Date:  2022-04-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.